Warren Seeds
Addiction Medicine · Las Vegas, NVNPI 1578538195
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Indivior Inc. accounts for 76.1% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $6,611 and has fallen 99.4% since, to $40 in 2023.
Across 83 payments — averaging $88.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$6K
- Neuronetics, Inc.$861
- Scilex Pharmaceuticals Inc.$149
- Arbor Pharmaceuticals, Inc.$127
- Nevro Corp.$63
- Biodelivery Sciences International, Inc.$61
- plus $495 from 20 others
What the payments were for
- Speaking & faculty fees$3,70050%
- Travel & lodging$1,74024%
- Food & beverage$1,89326%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 20 | $5,578 |
| Neuronetics, Inc. | 7 | $861 |
| Scilex Pharmaceuticals Inc. | 11 | $149 |
| Arbor Pharmaceuticals, Inc. | 6 | $127 |
| Nevro Corp. | 2 | $63 |
| Biodelivery Sciences International, Inc. | 4 | $61 |
| Pfizer | 4 | $58 |
| Orexo US, Inc. | 3 | $52 |
| Zyla Life Sciences, Inc. | 3 | $37 |
| Medtronic | 2 | $36 |
| Forte Bio-pharma LLC | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| AbbVie | 2 | $28 |
| Assertio Therapeutics, Inc. | 2 | $25 |
| Boston Scientific | 2 | $24 |
| IBSA Pharma Inc. | 1 | $24 |
| Si-bone, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Abbott | 1 | $18 |
| USWM, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
| AstraZeneca | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUBLOCADE$5,451
- NEUROSTAR TMS THERAPY$623
How this compares
Too few addiction medicine providers in Nevadato place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 46 | $10,449 |
| Buprenorphine Hcl | 34 | $2,073 |
| Gabapentin | 15 | $459 |
| Sumatriptan Succinate | 12 | $137 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in Las Vegas
- Paul NguyenLas Vegas$14K
- Muhammad HyderLas Vegas$2K
- Michael LevyLas Vegas$588
- Ozoemena AkahLas Vegas$14
- Charlene LetchfordReno$449
- Ryan LeyReno$385
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.